Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia
scientific article
Author/s
author: Xavier Leleu, Brianna Harris, Antonio Sacco, Aldo M Roccaro, Kenneth C. Anderson, Paul G. Richardson, Irene Ghobrial, Abdel Kareem Azab, Feda Azab, Fangxin Hong, Stacey Chuma, Scott Rodig, Peter Sportelli
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.